TipRanks on MSN
MicroPort NeuroTech’s Promising Stent Trial: A Potential Game-Changer in Cerebral Artery Treatment
MicroPort NeuroTech Limited ((HK:2172)) announced an update on their ongoing clinical study.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing ...
Scientists have identified a new anti-ageing drug class that works by acting on a key gut bacteria process, an advance that ...
Palvella Therapeutics reports progress in clinical trials for QTORIN™ rapamycin, exceeding patient enrollment and anticipating significant results in upcoming years. Net loss of $8.2 million for the ...
Rapamycin is typically prescribed as an immunosuppressive, but off-label users believe it can do much more. By Dana G. Smith Dana Smith interviewed eight longevity-focused researchers and clinicians ...
The 'Bust Big Pharma' bus tour, organized by Americans for Pharma Reform, has been garnering attention in battleground states. But information about the funders and founders of the organization is ...
To keep himself healthy into his eighth decade, David Sandler recently decided to go beyond his regular workouts and try something experimental: taking rapamycin, an unproven but increasingly popular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results